VAISHALI
Start SIP
Invest Now
Start SIP in VAISHALI
Performance
- Low
- ₹10
- High
- ₹10
- 52 Week Low
- ₹9
- 52 Week High
- ₹20
- Open Price₹10
- Previous Close₹10
- Volume57,596
Investment Returns
- Over 1 Month -10.08%
- Over 3 Month -20.81%
- Over 6 Month -24.29%
- Over 1 Year -41.85%
Smart Investing Starts Here Start SIP with Vaishali Pharma for Steady Growth!
Vaishali Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -325.4
- PEG Ratio
- 2.4
- Market Cap Cr
- 126
- P/B Ratio
- 1.9
- Average True Range
- 0.46
- EPS
- 0.04
- Dividend Yield
- 0
- MACD Signal
- -0.42
- RSI
- 28.63
- MFI
- 39.42
Vaishali Pharma Financials
Vaishali Pharma Technicals
EMA & SMA
Current Price
₹9.63
+
0.07
(0.73%)
- Bearish Moving Average 15
- Bullish Moving Average 1
- 20 Day
- ₹10.05
- 50 Day
- ₹10.77
- 100 Day
- ₹11.50
- 200 Day
- ₹12.59
Resistance and Support
9.65
- R3 10.04
- R2 9.92
- R1 9.77
- S1 9.50
- S2 9.38
- S3 9.23
Vaishali Pharma Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-14 | Quarterly Results | |
| 2025-08-11 | Quarterly Results & Others | To consider other business matters split from Rs. 10/- to Rs. 2/-. |
| 2025-05-28 | Audited Results & Others | To consider other business matters split from Rs. 10/- to Rs. 2/-. |
| 2025-02-06 | Quarterly Results & Others | To consider other business matters split from Rs. 10/- to Rs. 2/-. |
| 2025-01-28 | Others | To consider other business matters split from Rs. 10/- to Rs. 2/-. |
Vaishali Pharma F&O
About Vaishali Pharma
- NSE Symbol
- VAISHALI
- BSE Symbol
- Chairman & Managing Director
- Mr. Atul Arvind Vasani
- ISIN
- INE972X01022
Similar Stocks to Vaishali Pharma
Vaishali Pharma FAQs
Vaishali Pharma share price is ₹9 As on 17 November, 2025 | 08:14
The Market Cap of Vaishali Pharma is ₹125.6 Cr As on 17 November, 2025 | 08:14
The P/E ratio of Vaishali Pharma is -325.4 As on 17 November, 2025 | 08:14
The PB ratio of Vaishali Pharma is 1.9 As on 17 November, 2025 | 08:14
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.